The sense of smell is interrelated with psychosocial functioning. Olfactory disorders often
decrease quality of life but treatment options for people with olfactory loss are limited …

The postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
infection (PASC), also known as post‐acute coronavirus disease 19 (COVID‐19) or the long …

In this study, we investigated whether treatment with palmitoylethanolamide and luteolin
(PEA-LUT) leads to improvement in the quantitative or qualitative measures of olfactory …

Introduction The current study evaluated the use of platelet‐rich plasma (PRP), an
autologous blood product with supraphysiologic concentrations of growth factors, in the …

Luteolin (3′, 4′, 5, 7-tetrahydroxyflavone), a member of the flavonoid family derived from
plants and fruits, shows a wide range of biomedical applications. In fact, due to its anti …

Objectives To explore the neuropsychological profile and the integrity of the olfactory
network in patients with COVID-19-related persistent olfactory dysfunction (OD). Methods …

Background Lingering symptoms after acute COVID-19 present a major challenge to
ambulatory care services. Since there are reservations regarding their optimal management …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes coronavirus
disease 2019 (COVID‐19), a respiratory illness that poses a serious threat to global public …

Objective Transcranial magnetic stimulation (TMS) studies showed that patients with
cognitive dysfunction and fatigue after COVID-19 exhibit impaired cortical GABA B-ergic …

In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related
conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least …